What are the latest funding news in the healthcare AI market? (July 2026)

Last updated: 9 July 2026

Download our beautiful pitch about the healthcare AI market

market research pitch 2026 statistics healthcare AI market

In our healthcare AI market deck, you will find everything you need to understand the market

Healthcare AI funding stayed active in July 2026, with the newest disclosed rounds stretching from early Alzheimer’s diagnostics to clinical automation and life sciences workflows.

The latest cohort shows that investors are still backing tools that reduce healthcare labor pressure, automate clinical administration, and support faster research.

The biggest rounds went to companies already selling into providers or life sciences customers, which shows that commercial proof matters in this market.

And if you want to better understand this new industry, you can download our pitch covering the healthcare AI market.

Insights

  • Provider workflow automation dominated the newest healthcare AI funding news, with Assort Health, Prosper AI, Heidi Health, Telepatia, and Adaptive Innovations all targeting clinical labor bottlenecks
  • The three largest rounds, Assort Health, Cadence, and Collate, raised $315M combined, showing that scaled healthcare AI platforms are still attracting growth capital
  • Life sciences AI remained a strong subcategory, with Collate, Ingenix, and Novellia together raising about $128M for research, documentation, and real-world data workflows
  • Clinical AI funding was not limited to software behind the scenes, as Flok Health and Cadence both connect AI directly to patient care delivery
  • The latest healthcare AI rounds were geographically diverse, with India, Australia, Latin America, Poland, the UK, and the US all represented in the newest deal flow
  • AI patient access became one of the clearest funding themes, with Assort Health and Prosper AI raising $150M combined for scheduling, intake, insurance, and billing workflows
  • Valuation disclosure remained limited, but Assort Health and Collate show that healthcare AI companies can reach unicorn or near-unicorn levels when adoption is clear
Google Trends chart showing rising interest in AI for healthcare

As this chart shows, and as featured in our healthcare AI market deck, search interest in healthcare AI has grown rapidly

Summary table of the latest funding deals in the healthcare AI market as of July 2026

We define the healthcare AI market as AI software and models used by healthcare providers, payers, life sciences companies, medtech firms, and public health bodies to improve clinical care, operations, and research.

We include clinical decision support, diagnostic and monitoring tools, hospital and clinic workflow and revenue cycle automation, payer analytics and claims tools, as well as AI used in pharma and biotech R&D, clinical trials, and connected medical devices.

We exclude general-purpose AI infrastructure, pure consumer wellness and fitness apps, and horizontal enterprise tools that are not purpose-built or primarily sold for healthcare use.

You can also read our detailed analysis to understand how funding activity in the healthcare AI market has evolved over the last few years.

We also have a quarter-by-quarter analysis of funding activity in the market here.

Finally, you can check our complete list of fundraising deals for the healthcare AI market (we update this list every quarter) as well as our ranking of the most funded startups.

Name When Amount in $ Round Type Category
eNLife Research 8 July 2026 $0.70M Seed Diagnostic AI & Biomarker Analytics
Heidi Health 26 June 2026 $16.60M Series A follow-on Clinical Documentation AI
Assort Health 24 June 2026 $120.00M Series C Patient Access Automation
Cadence 23 June 2026 $100.00M Series C Chronic Care AI
Prosper AI 22 June 2026 $30.00M Series A Patient Journey Automation
Telepatia 22 June 2026 $33.00M Series A Clinical Workflow AI
Collate 3 June 2026 $95.00M Series B Life Sciences Documentation AI
Flok Health 3 June 2026 $12.50M Series A Autonomous MSK Care
Ingenix 3 June 2026 $15.00M Seed extension Pharma R&D AI
Adaptive Innovations 2 June 2026 $50.00M Series A Home Healthcare Automation
Subtle Medical 2 June 2026 $33.00M Series C Medical Imaging AI
Novellia 2 June 2026 $18.00M Series A Real-World Data AI

All the latest funding deals during in the healthcare AI market as of July 2026

eNLife Research raised about $0.70M in seed funding in July 2026

When was it?

The deal was announced on 8 July 2026.

Who are they?

eNLife Research builds an AI-powered blood biomarker test to detect Alzheimer’s disease years before symptoms appear.

Geographical focus?

eNLife Research is focused first on India, with diagnostics built around Indian population data and accessibility needs.

Why do we include them in the healthcare AI market?

eNLife Research belongs in healthcare AI because its core product uses AI for diagnostic biomarker analytics in neurodegenerative disease.

What is the company stage?

eNLife Research is at an early R&D and seed stage, with funding aimed at validating the test.

How much did they raise?

eNLife Research raised about $0.70M, based on the reported Rs 6 crore seed financing.

What round is it?

The round was a seed round led by Piper Serica VC Fund.

Why did they raise?

eNLife Research raised to advance a cheaper and less invasive AI-based blood test for early Alzheimer’s detection.

Heidi Health raised $16.6M in follow-on Series A funding in June 2026

When was it?

The deal was announced on 26 June 2026.

Who are they?

Heidi Health provides an AI medical scribe that automates clinical notes, pre-charting, documentation, and other clinician admin work.

Geographical focus?

Heidi Health has global traction, with users and customers across Australia, the US, the UK, Canada, New Zealand, and Europe.

Why do we include them in the healthcare AI market?

Heidi Health fits healthcare AI because its product is clinical documentation AI for provider workflow automation.

What is the company stage?

Heidi Health is at a growth stage, with strong product-market fit in clinician productivity and documentation workflows.

How much did they raise?

Heidi Health raised $16.6M in this latest funding round.

What round is it?

The round was a Series A follow-on led by Headline.

Why did they raise?

Heidi Health raised to expand beyond scribing into pre-chart summaries, guideline support, and patient-facing workflows.

Chart comparing business model options for ambient AI companies

This chart, featured in our healthcare AI market deck, compares the main business model options for ambient AI companies

Assort Health raised $120M in Series C funding in June 2026

When was it?

The deal was announced on 24 June 2026.

Who are they?

Assort Health uses voice AI to automate patient access workflows such as scheduling, intake, referrals, refills, eligibility checks, and payments.

Geographical focus?

Assort Health is focused on US provider groups and health systems.

Why do we include them in the healthcare AI market?

Assort Health belongs in healthcare AI because its AI agents automate operational workflows for healthcare providers.

What is the company stage?

Assort Health is at a late growth stage, with scaled commercial adoption across patient journey workflows.

How much did they raise?

Assort Health raised $120M in this round at a reported $1.2B valuation.

What round is it?

The round was a Series C led by Menlo Ventures.

Why did they raise?

Assort Health raised to expand its AI patient journey platform across provider groups and health systems.

Cadence raised $100M in Series C funding in June 2026

When was it?

The deal was announced on 23 June 2026.

Who are they?

Cadence runs an AI-powered chronic care model for older adults across major health systems.

Geographical focus?

Cadence is focused on the United States and works with major US health systems.

Why do we include them in the healthcare AI market?

Cadence fits healthcare AI because its platform uses AI for chronic disease monitoring, care management, and clinical workflow support.

What is the company stage?

Cadence is at a growth stage, with active deployments across leading health systems.

How much did they raise?

Cadence raised $100M in this round.

What round is it?

The round was a Series C led by Spark Capital.

Why did they raise?

Cadence raised to expand its AI-enabled chronic care model and automate more care for older adults with chronic disease.

Source: HLTH
Chart showing Tempus AI’s strategy in the healthcare AI market

This chart, featured in our healthcare AI market deck, looks at Tempus AI’s strategy in healthcare AI

Prosper AI raised $30M in Series A funding in June 2026

When was it?

The deal was announced on 22 June 2026.

Who are they?

Prosper AI builds AI phone agents and workflow automation for scheduling, insurance, billing, and payer calls.

Geographical focus?

Prosper AI operates from New York and Madrid, with a focus on healthcare providers.

Why do we include them in the healthcare AI market?

Prosper AI fits healthcare AI because its platform automates patient journey operations for healthcare organizations.

What is the company stage?

Prosper AI is at an early growth stage, with Series A backing and expanding provider adoption.

How much did they raise?

Prosper AI raised $30M in this round.

What round is it?

The round was a Series A led by Andreessen Horowitz.

Why did they raise?

Prosper AI raised to grow engineering and customer teams and deepen integrations with electronic health record systems.

Telepatia raised $33M in Series A funding in June 2026

When was it?

The deal was announced on 22 June 2026.

Who are they?

Telepatia builds an AI-native clinical platform with documentation, decision support, AI doctors, nurses, and auditors for hospitals.

Geographical focus?

Telepatia focuses on Latin America, especially Brazil, Colombia, and Mexico.

Why do we include them in the healthcare AI market?

Telepatia belongs in healthcare AI because its platform supports hospital productivity, clinical decision support, and care workflows.

What is the company stage?

Telepatia is at an early growth stage, with deployments across hospital systems in Latin America.

How much did they raise?

Telepatia raised $33M in this round.

What round is it?

The round was a Series A led by Andreessen Horowitz.

Why did they raise?

Telepatia raised to scale its AI healthcare platform across Latin America and expand hospital deployments.

Source: HLTH
Table scoring and prioritizing the main pain points faced by companies in the healthcare AI market

In our healthcare AI market deck, we identify pain points entrepreneurs should prioritize

Collate raised $95M in new funding in June 2026

When was it?

The deal was announced on 3 June 2026.

Who are they?

Collate automates complex documentation and regulatory paperwork for life sciences companies using AI.

Geographical focus?

Collate is based in the United States and sells to global pharma, medtech, diagnostics, and biotech customers.

Why do we include them in the healthcare AI market?

Collate fits healthcare AI because its platform automates regulatory, clinical trial, and product development documentation for life sciences teams.

What is the company stage?

Collate is at a growth stage, with strong product-market fit and a reported near-unicorn valuation.

How much did they raise?

Collate raised $95M in this round.

What round is it?

The round was described as a new round, often reported as Series B, led by Redpoint Ventures.

Why did they raise?

Collate raised to scale AI workflows for life sciences regulatory documentation, clinical trials, and product development.

Flok Health raised $12.5M in Series A funding in June 2026

When was it?

The deal was announced on 3 June 2026.

Who are they?

Flok Health runs an AI-operated physiotherapy clinic for musculoskeletal conditions such as back pain.

Geographical focus?

Flok Health is UK and NHS-first, with international expansion planned.

Why do we include them in the healthcare AI market?

Flok Health belongs in healthcare AI because its autonomous AI clinic delivers MSK care and digital therapeutics.

What is the company stage?

Flok Health is at an early growth stage, with NHS rollout and regulated clinical delivery.

How much did they raise?

Flok Health raised $12.5M in this round.

What round is it?

The round was a Series A led by Albion VC.

Why did they raise?

Flok Health raised to scale its AI physiotherapy service across the NHS and expand into more MSK and women’s health conditions.

Market map chart showing top companies and startups in the healthcare AI market

This market map, featured in our healthcare AI market deck, highlights top companies and startups in the healthcare AI market

Ingenix raised about $15M in seed-extension funding in June 2026

When was it?

The deal was announced on 3 June 2026.

Who are they?

Ingenix builds a Biological Reasoning Engine that uses AI to understand biology and support drug development.

Geographical focus?

Ingenix is based in Poland and serves pharma and biotech partners globally.

Why do we include them in the healthcare AI market?

Ingenix fits healthcare AI because its AI platform supports pharma R&D, biological modeling, and drug development.

What is the company stage?

Ingenix is at a seed-extension and early platform scale-up stage.

How much did they raise?

Ingenix raised about $15M, based on the reported €13M round.

What round is it?

The round was a seed extension led by Sofinnova Partners.

Why did they raise?

Ingenix raised to scale its Biological Reasoning Engine and broaden work with pharma and biotech partners.

Adaptive Innovations raised $50M in Series A funding in June 2026

When was it?

The deal was announced on 2 June 2026.

Who are they?

Adaptive Innovations builds an AI-native home healthcare provider and operating system for home-based clinical services.

Geographical focus?

Adaptive Innovations focuses on the United States, with operations including New York City and Dallas.

Why do we include them in the healthcare AI market?

Adaptive Innovations fits healthcare AI because its model uses AI to automate provider operations in home healthcare.

What is the company stage?

Adaptive Innovations is at an early growth stage after emerging from stealth.

How much did they raise?

Adaptive Innovations raised $50M in this Series A round.

What round is it?

The round was a Series A led by Felicis.

Why did they raise?

Adaptive Innovations raised to build and scale an AI-native home healthcare agency that reduces administrative burden and improves clinical labor use.

Chart showing the projected CAGR of the healthcare AI market

This chart, featured in our healthcare AI market deck, shows annual funding in healthcare AI startups

Subtle Medical raised $33M in growth capital in June 2026

When was it?

The deal was announced on 2 June 2026.

Who are they?

Subtle Medical makes AI imaging software that improves scan speed, image quality, and patient experience in MRI and other imaging workflows.

Geographical focus?

Subtle Medical is US-based and sells globally to hospitals and imaging centers.

Why do we include them in the healthcare AI market?

Subtle Medical belongs in healthcare AI because its software uses AI for diagnostic imaging and radiology workflow improvement.

What is the company stage?

Subtle Medical is at a growth stage, with commercial imaging software and global provider customers.

How much did they raise?

Subtle Medical raised $33M in growth capital.

What round is it?

The financing was anchored by a Series C led by Morgan Stanley Expansion Capital.

Why did they raise?

Subtle Medical raised to accelerate commercialization and set a faster, higher-quality standard for medical imaging.

Novellia raised $18M in Series A funding in June 2026

When was it?

The deal was announced on 2 June 2026.

Who are they?

Novellia builds an AI-powered, patient-permissioned real-world data platform for pharma research and medical discovery.

Geographical focus?

Novellia is US-based and focused on life sciences and research customers.

Why do we include them in the healthcare AI market?

Novellia fits healthcare AI because its platform uses AI to organize patient health histories for pharma R&D and clinical research.

What is the company stage?

Novellia is at a Series A and early commercial growth stage, with life sciences customer traction.

How much did they raise?

Novellia raised $18M in this round.

What round is it?

The round was a Series A led by Spark Capital.

Why did they raise?

Novellia raised to scale its AI-powered platform that organizes health histories and lets patients contribute data to medical research.

Who is the author of this content?

NEW MARKET PITCH TEAM

We track new markets so founders and investors can move faster

We build living “market pitch” documents for emerging markets: from AI to synthetic biology and new proteins. Instead of digging through outdated PDFs, random blog posts, and hallucinated LLM answers, our clients get a clean, visual, always-updated view of what’s really happening. We map the key players, deals, regulations, metrics and signals that matter so you can decide faster whether a market is worth your time. Want to know more? Check out our about page. You can also follow us on Instagram or on Facebook.

How we created this content 🔎📝

At New Market Pitch, we kept seeing the same problem: when you look at a new market, the data is either missing, paywalled, or buried in 300-page reports that feel like they were written in the 80s. On the other side, LLMs and random blog posts give you confident answers with no sources, and sometimes they just make things up. That’s not good enough when you’re about to invest real money or launch a company.

So we decided to fix the experience. For each market we cover, we build a structured database and update it on a regular basis. We track funding rounds, fund memos, M&A moves, partnerships, new products, policy changes, and the real activity of startups and incumbents. Then we turn all of that into a clear “market pitch” that shows where the opportunities are and how people actually win in that space.

Every key data point is checked, sourced, and put back into context by our team. That’s how we can give you both speed and reliability: fast coverage of new markets, without the usual guesswork.

Back to blog